LEO Pharma, specializing in medical dermatology and thrombosis, saw a 7% revenue increase in 2023, reaching €1.54 billion in net sales. In Spain, growth was 6.9%,...
Novo Nordisk sees substantial growth, reporting a 28% increase in profits to €3.4 billion in Q1 2024, with operating profits up 27% to €4.27 billion. This...
Wegovy stands as Novo Nordisk's big bet. This medicine was what placed the Danish multinational company as the most valuable company in Europe last September, surpassing...
Novo Nordisk plans a €2.1 billion investment to strengthen its presence in France's industrial sector, according to French President. The biotech company aims to expand the...
Novo Nordisk increased its profit by 42.5% in the first half of 2023, reaching 39,242 million Danish crowns (€5.26 million). The firm has decided to increase...